Gap in care events per admission
| Variable | Alerts on n=2472 admissions | Alerts off n=2489 admissions | OR (on vs off) | Unadjusted p value | Adjusted p value |
| All gap in care events | |||||
| Total events across all admissions | 7707 | 8326 | |||
| Number of events per admission | 3.12±2.93 | 3.35±3.24 | 0.97 (0.92 to 1.03) | 0.347 | 0.438 |
| Events of hyperglycemia in subjects with diabetes | |||||
| Total events across all admissions | 3342 | 3701 | |||
| Admissions with at least one event | 1586 (64.2) | 1666 (66.9) | 0.88 (0.79 to 0.98) | 0.023 | 0.05 |
| Number of events per admission | 1.35±1.65 | 1.49±1.86 | 0.94 (0.87 to 1.02) | 0.12 | 0.179 |
| Events of stress hyperglycemia | |||||
| Total events across all admissions | 288 | 506 | |||
| Admissions with at least one event | 185 (7.5) | 310 (12.5) | 0.60 (0.51 to 0.72) | <0.001 | <0.001 |
| Number of events per admission | 0.12±0.58 | 0.20±0.70 | 0.59 (0.46 to 0.76) | <0.001 | <0.001 |
| Events of hypoglycemia or impending hypoglycemia | |||||
| Total events across all admissions | 1548 | 1349 | |||
| Admissions with at least one event | 910 (36.8) | 826 (33.2) | 1.15 (1.02 to 1.29) | 0.023 | 0.05 |
| Number of events per admission | 0.63±1.08 | 0.54±1.04 | 1.22 (1.07 to 1.40) | 0.003 | 0.010 |
| Events of inappropriate insulin use as sliding scale monotherapy in patients with type 1 diabetes | |||||
| Total events across all admissions | 10 | 22 | |||
| Admissions with at least one event | 6 (0.2) | 16 (0.6) | 0.36 (0.13 to 0.97) | 0.044 | 0.073 |
| Number of events per admission | 0.0±0.09 | 0.01±0.12 | 0.12 (0.02 to 0.63) | 0.012 | 0.035 |
| Events of inappropriate insulin use as sliding scale monotherapy in patients with type 2 diabetes | |||||
| Total events across all admissions | 2519 | 2748 | |||
| Admissions with at least one alert | 1069 (43.2) | 1096 (44.0) | 0.97 (0.87 to 1.08) | 0.59 | 0.632 |
| Number of events per admission | 1.02±1.72 | 1.10±1.88 | 0.96 (0.87 to 1.05) | 0.38 | 0.438 |
| Events of Inappropriate insulin use as sliding scale monotherapy in patients with stress hyperglycemia | |||||
| Total events across all admissions | 1617 | 1488 | |||
| Admissions with at least one event | 695 (28.1) | 575 (23.1) | 1.30 (1.16 to 1.46) | <0.001 | <0.001 |
| Number of events per admission | 0.65±1.47 | 0.60±1.55 | 1.16 (1.02 to 1.33) | 0.027 | 0.05 |
| Events of hypoglycemia events following the first non-hypoglycemia event | |||||
| Total events across all admissions | 668 | 619 | |||
| Number of events per admission | 1.69±1.08 | 1.70±1.19 | 1.02 (0.86 to 1.21) | 0.846 | 0.846 |
| Events of hypoglycemia events following the first hypoglycemia event | |||||
| Total events across all admissions | 638 | 523 | |||
| Number of events per admission | 1.78±1.23 | 1.87±1.40 | 1.09 (0.91 1.30) | 0.361 | 0.438 |
N(%); Effect size = Odds Ratio from binomial generalized estimating equations (GEE) model.
Mean± SD; Effect size=Incidence Rate Ratio from Poisson generalized estimating equations (GEE) model.
IRR, incidence rate ratio.